MPS Powered by Eureka

Current Alzheimer Research

ISSN: 1567-2050 (Print)
eISSN: 1875-5828 (Online)

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies, letter articles, case reports, systematic reviews, and editorials on all areas of Alzheimer's disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, diagnosis and treatment strategies of Alzheimer's disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer's disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer's disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.
Journal Impact Factor : 1.8

Special Issues With Active Call for Papers

Submission closes on: Apr 15, 2025
Integrative Perspectives on Neurodegeneration and Aging: From Molecular Insights to Therapeutic Strategies

The increasing burden of age-related neurodegenerative diseases demands an immediate and pressing need for research in all aspects, from molecular mechanisms to therapeutic interventions. The special issue in Current Alzheimer Research "Integrative Perspectives on Neurodegeneration and Aging: From Molecular Insights to Therapeutic Strategies" aims to highlight the summary of state-of-the-art advances and perspectives into the understanding and management of these disorders. With the aging population of the world, there is an increasing incidence of these... see more

Submission closes on: Dec 31, 2024
Linear and Non-Linear Signals from the Brain: from the Basic to Clinical Application

Neurodegenerative diseases are increasing in the general population and have been defined by the World Health Organization (WHO) and Alzheimer's Disease International (ADI) as a global public health priority. Data from the WHO Global Action Plan 2017-2025 indicates that in 2015, neurodegeneration-related diseases affected 47 million people worldwide, a figure expected to increase to 75 million by 2030 and 132 million by 2050, with approximately 10 million new cases per year (1 every 3 seconds).... see more

Submission closes on: Dec 31, 2024
Diagnostic and therapeutic biomarkers of dementia

Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder professional activity, social functioning, and performing daily activities. The most common types of dementia are Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). Vascular... see more

Submission closes on: Dec 25, 2024
Early nutritional intervention and physical activity in the prevention of Alzheimer's disease and other dementias

The aim is to broaden the knowledge about the impact of the consumption of food ingredients, diet ingredients, methods of processing of food raw materials as well as the impact of composing of diets on the possibility of preventing Alzheimer's disease and other types of dementia at each stage of life. This Thematic Issue aims to gather the most recent role of foods from all over the world as well as individual food ingredients in... see more

Submission closes on: Dec 10, 2024
Regulation of Immunosenescence in Neurodegenerative Disorders: Mechanisms, Implications, and Therapeutic Strategies

Scope: Growing evidence has suggested that immunosenescence, an aging-associated change in immune function, plays a critical role in the progression and severity of neurodegenerative disorders including Alzheimer's disease (AD), Parkinson's disease, Huntington's disease, and multiple sclerosis. This special issue aims to investigate the mechanisms underlying immune cell aging and exhaustion, their role in neuroinflammation, and their contribution to the pathology of neurodegenerative disorders. By focusing on recent advancements in understanding how aging immune cells influence... see more

Submission closes on: Nov 30, 2024
Leading Alzheimer Disease Prevention with Precision Health Strategies.

The rising number of patients with Alzheimer’s disease (AD) is a concerning reality in our society. Despite tremendous public-private efforts, finding an appropriate treatment for Alzheimer’s disease prevention has not been successful. One of the reasons behind this failure is the urge to find “a treatment that fits all sizes”, ignoring the focus on “the right drug, the right dose, and the right people”. Notably, AD patients have several clinical comorbidities, such as diabetes, obesity,... see more